(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -6.20%7.93B | -14.44%17.12B | -15.71%8.45B | 8.74%20.01B | 20.19%10.03B | 30.47%18.4B | 37.65%8.34B | 17.10%14.1B | 9.41%6.06B | 13.76%12.04B |
Operating income | -6.20%7.93B | -14.44%17.12B | -15.71%8.45B | 8.74%20.01B | 20.19%10.03B | 30.47%18.4B | 37.65%8.34B | 17.10%14.1B | 9.41%6.06B | 13.76%12.04B |
Cost of sales | 5.49%-6.09B | 14.87%-13.11B | 14.51%-6.45B | -14.16%-15.41B | -24.74%-7.54B | -35.17%-13.49B | -37.11%-6.05B | -18.02%-9.98B | -11.05%-4.41B | -15.24%-8.46B |
Operating expenses | 5.49%-6.09B | 14.87%-13.11B | 14.51%-6.45B | -14.16%-15.41B | -24.74%-7.54B | -35.17%-13.49B | -37.11%-6.05B | -18.02%-9.98B | -11.05%-4.41B | -15.24%-8.46B |
Gross profit | -8.48%1.83B | -12.98%4B | -19.37%2B | -6.20%4.6B | 8.19%2.48B | 19.08%4.9B | 39.10%2.29B | 14.94%4.12B | 5.25%1.65B | 10.43%3.58B |
Selling expenses | -1.18%-425.95M | 8.49%-868.35M | 17.66%-420.99M | -0.57%-948.87M | -13.33%-511.29M | -29.35%-943.47M | -53.26%-451.14M | -18.11%-729.41M | -10.77%-294.36M | -24.63%-617.55M |
Administrative expenses | 8.02%-1.11B | 19.49%-1.35B | 16.26%-1.21B | 4.16%-1.68B | -4.63%-1.45B | -34.84%-1.76B | -54.10%-1.38B | -8.87%-1.3B | -7.63%-896.48M | -9.60%-1.2B |
Research and development expenses | ---- | 12.90%-1.08B | ---- | 0.90%-1.24B | ---- | -34.31%-1.25B | ---- | -14.98%-930.17M | ---- | -9.40%-808.95M |
Impairment and provision | -4.43%-15.46M | -56.16%-139.69M | -13.89%-14.8M | 19.94%-89.45M | 13.92%-13M | 43.89%-111.74M | -0.80%-15.1M | -80.08%-199.12M | -21.50%-14.98M | -214.13%-110.57M |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 38.88%-21.86M | ---- | ---35.76M |
-Other impairment is provision | -4.43%-15.46M | -56.16%-139.69M | -13.89%-14.8M | 19.94%-89.45M | 13.92%-13M | 36.97%-111.74M | -0.80%-15.1M | -136.94%-177.26M | -21.50%-14.98M | -112.53%-74.81M |
Special items of operating profit | 68.73%118.95M | 24.13%374.77M | -53.08%70.5M | -40.52%301.92M | -14.16%150.26M | 122.14%507.58M | 96.24%175.05M | 98.94%228.5M | 299.29%89.2M | 2,439.29%114.86M |
Operating profit | -7.00%395.67M | -0.67%936.78M | -35.76%425.46M | -30.23%943.09M | 6.64%662.32M | 13.94%1.35B | 16.66%621.1M | 22.93%1.19B | 11.36%532.39M | 9.85%965M |
Financing cost | -20.16%-99.84M | -79.16%-202.83M | -60.19%-83.09M | -13.72%-113.21M | -15.38%-51.87M | 34.27%-99.56M | 50.15%-44.96M | 8.78%-151.46M | -5.58%-90.18M | -40.73%-166.05M |
Earning before tax | -13.59%295.83M | -11.56%733.95M | -43.91%342.37M | -33.72%829.88M | 5.96%610.45M | 20.99%1.25B | 30.29%576.14M | 29.52%1.03B | 13.34%442.21M | 5.06%798.96M |
Tax | -226.06%-10.48M | 70.05%-21.28M | 121.01%8.31M | 38.42%-71.05M | 33.09%-39.57M | -33.04%-115.39M | -31.12%-59.15M | -105.18%-86.73M | -44.50%-45.11M | 4.54%-42.27M |
After-tax profit from continuing operations | -18.63%285.35M | -6.08%712.67M | -38.57%350.69M | -33.24%758.83M | 10.42%570.88M | 19.89%1.14B | 30.19%517M | 25.30%948.11M | 10.62%397.11M | 5.66%756.69M |
Earning after tax | -18.63%285.35M | -6.08%712.67M | -38.57%350.69M | -33.24%758.83M | 10.42%570.88M | 19.89%1.14B | 30.19%517M | 25.30%948.11M | 10.62%397.11M | 5.66%756.69M |
Minority profit | -7.62%-367K | -18.79%-727K | 49.41%-341K | -176.92%-612K | 7.16%-674K | 96.76%-221K | 83.01%-726K | -479.03%-6.82M | -14.62%-4.27M | 388.59%1.8M |
Profit attributable to shareholders | -18.60%285.72M | -6.06%713.39M | -38.58%351.03M | -33.20%759.44M | 10.40%571.55M | 19.06%1.14B | 28.99%517.72M | 26.50%954.93M | 10.67%401.38M | 5.46%754.89M |
Basic earnings per share | -12.14%0.1093 | -0.88%0.2588 | -36.60%0.1244 | -36.15%0.2611 | 3.70%0.1962 | 8.00%0.4089 | 16.65%0.1892 | 23.28%0.3786 | 10.79%0.1622 | 3.96%0.3071 |
Diluted earnings per share | -12.58%0.1056 | -0.48%0.2506 | -35.40%0.1208 | -34.43%0.2518 | 5.23%0.187 | 7.59%0.384 | 12.97%0.1777 | 18.77%0.3569 | 9.92%0.1573 | 7.74%0.3005 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data